Editorial: Adjuvant anthracyclines and taxanes: Quantifying the costs of therapeutic advances in breast cancer Journal Article


Authors: Morris, P. G.; Bach, P. B.
Article Title: Editorial: Adjuvant anthracyclines and taxanes: Quantifying the costs of therapeutic advances in breast cancer
Keywords: protein expression; fluorouracil; drug efficacy; risk benefit analysis; systemic therapy; paclitaxel; cancer adjuvant therapy; comparative study; methotrexate; methodology; multiple cycle treatment; breast cancer; epidermal growth factor receptor 2; editorial; cyclophosphamide; high risk patient; docetaxel; febrile neutropenia; cost effectiveness analysis; drug cost; health care cost; hospitalization; health care system; epirubicin; cancer epidemiology; trastuzumab; granulocyte colony stimulating factor; hospitalization cost; cost benefit analysis; public health problem
Journal Title: Onkologie
Volume: 32
Issue: 8-9
ISSN: 0378-584X
Publisher: S. Karger AG  
Date Published: 2009-09-01
Start Page: 464
End Page: 466
Language: English
DOI: 10.1159/000227136
PROVIDER: scopus
PUBMED: 19745589
DOI/URL:
Notes: --- - "Export Date: 30 November 2010" - "CODEN: ONKOD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Patrick Glyn Morris
    116 Morris
  2. Peter Bach
    255 Bach